11 August 2022 · Colistimethate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
4 November 2020 · Monitor infant for gastro-intestinal disturbances and oral candida infection, especially if used for prolonged periods or in high doses, although these effects are unlikely to…